Abstract:This work developed a biohybrid bacterial system through genetic engineering and biomaterial hybridization in which CDH17 nanobodies are engineered onto the bacteria for tumor targeting and a photothermal material croconium (CR) dye is conjugated on bacteria for PTT induction. When combined with checkpoint blockade CD47 nanobody, the biohybrid bacteria successfully eradicated the tumors through STING activation, and considerably extended survival of the mice. Bacteria can be utilized for cancer therapy owing to their preferential colonization at tumor sites. However, unmodified non‐pathogenic bacteria carry potential risks due to their non‐specific targeting effects, and their anti‐tumor activity is limited when used as monotherapy. In this study, a biohybrid‐engineered bacterial system comprising non‐pathogenic MG1655 bacteria modified with CDH17 nanobodies on their surface and conjugated with photosensitizer croconium (CR) molecules is developed. The resultant biohybrid bacteria can efficiently home to CDH17‐positive tumors, including gastric, pancreatic, and colorectal cancers, and significantly suppress tumor growth upon irradiation. More importantly, biohybrid bacteria‐mediated photothermal therapy (PTT) induced abundant macrophage infiltration in a syngeneic murine colorectal model. Further, that the STING pathway is activated in tumor macrophages by the released bacterial nucleic acid after PTT is revealed, leading to the production of type I interferons. The addition of CD47 nanobody but not PD‐1 antibody to the PTT regimen can eradicate the tumors and extend survival. This results indicate that bacteria endowed with tumor‐specific selectivity and coupled with photothermal payloads can serve as an innovative strategy for low‐immunogenicity cancers. This strategy can potentially reprogram the tumor microenvironment by inducing macrophage infiltration and enhancing the efficacy of immunotherapy targeting macrophages.

Development of a TNF-α-mediated Trojan Horse for bacteria-based cancer therapy

A Bacteria-Based System Expressing Anti-Tnf-α Nanobody for Enhanced Cancer Immunotherapy

Dual-engineered, “Trojanized” macrophages bio-modally eradicate tumors through biologically and photothermally deconstructing cancer cells in an on-demand, NIR-commanded, self-explosive manner

Bacteria‐Elicited Specific Thrombosis Utilizing Acid‐Induced Cytolysin A Expression to Enable Potent Tumor Therapy

Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor

Bacteria-Mediated Tumor Therapy Utilizing Photothermally-Controlled TNF-α Expression Via Oral Administration

Engineering of Bacteria for the Visualization of Targeted Delivery of A Cytolytic Anticancer Agent

Antibody-mediated targeting of TNFR2 activates CD8 + T cells in mice and promotes antitumor immunity.

Programmable Bacteria with Dynamic Virulence Modulation System for Precision Antitumor Immunity

Engineering Nano‐clustered Multivalent Agonists to Cross‐link TNF Receptors for Cancer Therapy

An engineered TNFR1-selective human lymphotoxin-alpha mutant delivered by an oncolytic adenovirus for tumor immunotherapy

Targeted Cancer Therapy with Tumor Necrosis Factor-Alpha.

Development of a Recombinant Xenogeneic Tumor Necrosis Factor Alpha Protein Vaccine to Protect Mice from Experimental Colitis.

Targeted Cancer Therapy Using Engineered Salmonella typhimurium.

Sonogenetics-controlled Synthetic Designer Cells for Cancer Therapy in Tumor Mouse Models

Macrophage-mediated tumor-targeted delivery of engineered Salmonella typhimurium VNP20009 in anti-PD1 therapy against melanoma

Nanobody‐Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING‐Mediated Anti‐Tumor Immunity

Engineered NIR light-responsive bacteria as anti-tumor agent for targeted and precise cancer therapy

Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity

IgG-Engineered Protective Antigen for Cytosolic Delivery of Proteins into Cancer Cells

Trojan Nanobacteria System for Photothermal Programmable Destruction of Deep Tumor Tissues